This International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS), designed to provide clear information to assist clinical decision making and support optimal patient care, is the culmination of the work of over 3,000 health professionals and consumers internationally.
We acknowledge the enthusiasm and engagement of the health professionals and women affected by PCOS, our partners European Society of Human Reproduction and Embryology and American Society for Reproductive Medicine and our collaborating and engaged professional societies and consumer advocacy and support organisations internationally. These stakeholders have guided scope, identification of gaps and needs, prioritisation of clinical questions and outcomes of importance, review of evidence, formulations of recommendations and the guideline, as well as development and implementation of the dissemination and translation program.
- Technical report (PDF, 11.8MB)
- Disclosure of interest process flow chart (PDF, 93KB)
- Register of disclosures of interest (xlsx, 50.5KB)
- Administrative report (PDF, 587KB)
- Public consultation comments and developer responses (xlsx, 159KB)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ; International PCOS Network.
- Clinical Endocrinology (Oxf). 2018 Sep;89(3):251-268. doi: 10.1111/cen.13795. Epub 2018 Jul 19.
- Fertility and Sterility. 2018 Aug;110(3):364-379. doi: 10.1016/j.fertnstert.2018.05.004. Epub 2018 Jul 19.
- Human Reproduction. 2018 Sep 1;33(9):1602-1618. doi: 10.1093/humrep/dey256. Epub 2018 Jul 19.
PCOS Guideline and translation program impact
View infographic (PDF, 171KB)